logologo

Get Quote

HomeNEWS&BLOGSGenesis Showcases Pipeline at ALDM 2024 in Chicago

Genesis Showcases Pipeline at ALDM 2024 in Chicago

2024-08-03
Key Words:ADLM, IVD, POCT

In the global landscape of biotechnology and medical diagnostics, Hangzhou Genesis Biodetection and Biocontrol Co., Ltd. has emerged as an important player. As a testament to its commitment to excellence and international outreach, the company is set to participate in the prestigious Association for Diagnostics & Laboratory Medicine (ALDM) Exhibition 2024, showcasing its latest products and promoting the Genesis brand on a global stage.

About Genesis: A Brief Introduction

Founded in 2002 in the vibrant Hangzhou Economic and Technological Development Zone, Hangzhou Genesis is a joint venture born from the collaboration between leading bio-diagnostic reagent companies in Japan and the United States, and supported by experienced domestic investors. With an expansive facility spanning 15,000 square meters, the company has established itself as a pioneering force in the field of in vitro diagnostic (IVD) reagents.

Over the years, Hangzhou Genesis has cultivated a reputation for excellence, leveraging advanced experimental techniques, sophisticated instrumentation, and a profound understanding of the industry. Its dedication to delivering high-quality medical diagnostic products and specialized technical services has earned it widespread recognition both domestically and internationally.

ALDM 2024: A Platform for Global Exposure

The ALDM Exhibition is a highly anticipated annual event that brings together the world's foremost players in laboratory diagnostics, medical devices, and related technologies. This prestigious platform provides an ideal opportunity for companies like Hangzhou Genesis to showcase their latest products, engage with industry peers, and explore new business opportunities.

At ALDM 2024, Hangzhou Genesis's booth was a hub of activity, attracting visitors from across the globe who are eager to learn more about Hangzhou Genesis's groundbreaking work in the field of IVD reagents.

Genesis Brand: A Global Vision

Participating in the ALDM 2024 is not just about showcasing products; it's also about promoting the Hangzhou Genesis brand and its unique value proposition to the world. By engaging with international partners, investors, and industry leaders, the company aims to further strengthen its global presence and solidify its position as a leading player in the IVD market.



EZER™ ADV Adenovirus Antigen Rapid Test
EZER™ GBS Screen Broth
Share
Next article